
  
    
      
        Introduction_NNP
        A_DT key_JJ component_NN regulating_VBG neuronal_NN migration_NN is_VBZ the_DT
        appropriate_JJ spatio-temporal_JJ expression_NN of_IN extracellular_NN
        matrix_NN (_( ECM_NNP )_) molecules_NNS which_WDT contribute_VBP to_TO the_DT highway_NN
        along_IN which_WDT neurons_NNS travel_VBP ._. Proteins_NNPS ,_, such_JJ as_IN serine_NN
        proteases_NNS and_CC their_PRP$ inhibitors_NNS ,_, could_MD alter_VB the_DT quality_NN of_IN
        this_DT highway_NN and_CC thus_RB play_VB critical_JJ roles_NNS in_IN migratory_NN
        processes_VBZ [_NN 1_CD ]_NN ._. Members_NNS of_IN the_DT serine_NN protease_NN inhibitor_NN
        superfamily_RB ,_, or_CC serpins_NNS ,_, act_NN by_IN binding_JJ to_TO and_CC permanently_RB
        inactivating_VBG their_PRP$ target_NN protease_NN (_( s_VBZ )_) ._. One_CD member_NN of_IN this_DT
        family_NN ,_, protease_NN nexin-_NN 1_CD (_( PN-_NNP 1_LS )_) ,_, was_VBD first_RB described_VBN by_IN
        Monard_NNP 
        et_CC al_NN ._. [_NN 2_CD ]_NN ._. Though_IN initially_RB
        characterized_VBN for_IN its_PRP$ ability_NN to_TO stimulate_VB neurite_NN
        outgrowth_NN [_NN 2_CD 3_CD 4_CD 5_CD ]_NN ,_, PN-_NNP 1_CD also_RB modulates_NNS neuronal_NN
        migration_NN as_IN exemplified_VBN by_IN Lindner_NNP 
        et_CC al_NN ._. [_NN 6_CD ]_NN ._. Their_PRP$ studies_NNS
        demonstrate_VBP that_IN PN-_NNP 1_CD slows_VBZ granule_NN cell_NN movement_NN from_IN the_DT
        external_JJ to_TO internal_JJ layers_NNS in_IN postnatal_NN mouse_NN cerebellar_NN
        slice_NN cultures_NNS ._.
        Interestingly_RB ,_, this_DT inhibition_NN of_IN migration_NN by_IN protease_NN
        inhibitors_NNS may_MD be_VB balanced_VBN by_IN the_DT stimulation_NN of_IN migration_NN
        via_IN proteases_NNS ._. For_IN example_NN 
        in_IN vitro_NN addition_NN of_IN plasmin_NN ,_, a_DT
        serine_NN protease_NN ,_, accelerates_VBZ the_DT migration_NN of_IN neuroblastoma_NN
        cells_NNS through_IN a_DT matrigel_NN base_NN by_IN a_DT factor_NN of_IN five_CD [_NN 7_CD ]_NN ._.
        The_DT subsequent_JJ addition_NN of_IN aprotinin_NN ,_, a_DT plasmin_NN inhibitor_NN ,_,
        decreases_VBZ the_DT migratory_NN population_NN to_TO the_DT same_JJ degree_NN [_NN 8_CD 9_CD
        ]_NN ._. Furthermore_RB ,_, Seeds_NNP 
        et_CC al_NN ._. [_NN 10_CD ]_NN demonstrated_VBD a_DT
        retardation_NN of_IN granule_NN cell_NN migration_NN in_IN tissue_NN plasminogen_NN
        activator_NN (_( tPA_NN )_) knock-out_JJ mice_NNS ._. These_DT data_NNS support_VBP the_DT
        hypothesis_NNS that_IN a_DT balance_NN exists_VBZ between_IN serine_NN proteases_NNS
        and_CC their_PRP$ inhibitors_NNS such_JJ that_IN changes_NNS in_IN this_DT balance_NN
        delay_NN or_CC promote_VB neuronal_NN migration_NN ._. The_DT present_JJ study_NN was_VBD
        initiated_VBN to_TO test_VB this_DT hypothesis_NNS 
        in_IN vivo_NN by_IN examining_VBG neuronal_NN
        migration_NN of_IN chick_NN gonadotropin_NN releasing_VBG hormone_NN (_( GnRH_NNP )_)
        neurons_NNS during_IN embryogenesis_NNS ._. The_DT site_NN of_IN origin_NN of_IN these_DT
        cells_NNS in_IN the_DT olfactory_NN placode_NN ,_, as_RB well_RB as_IN the_DT time_NN course_NN
        and_CC migratory_NN route_NN along_IN the_DT olfactory_NN nerve_NN (_( ON_NNP )_) and_CC into_IN
        the_DT forebrain_NN are_VBP well_RB documented_VBN [_NN 11_CD 12_CD 13_CD 14_CD ]_NN ._.
        Previous_JJ work_NN in_IN the_DT laboratory_NN has_VBZ shown_VBN that_IN olfactory_NN
        axons_NNS emerge_VBP from_IN the_DT olfactory_NN epithelium_NN at_IN stage_NN 18_CD and_CC
        are_VBP first_RB joined_VBN by_IN glia_NN [_NN 15_CD ]_NN and_CC GnRH_NNP neurons_NNS [_NN 16_CD ]_NN at_IN
        stage_NN 21_CD ._.
        In_IN order_NN to_TO test_VB whether_IN proteolysis_NNS or_CC its_PRP$ inhibition_NN
        affect_NN GnRH_NNP cellular_JJ migration_NN ,_, we_PRP performed_VBD experiments_NNS at_IN
        two_CD critical_JJ developmental_NN time_NN points_NNS ._. In_IN both_DT of_IN these_DT a_DT
        protease_NN or_CC its_PRP$ inhibitor_NN was_VBD applied_VBN by_IN placing_VBG
        protein-coated_JJ beads_NNS at_IN the_DT olfactory_NN placode_NN ._. The_DT first_JJ
        experiments_NNS tested_VBN whether_IN application_NN of_IN either_DT of_IN these_DT
        agents_NNS over_IN the_DT period_NN of_IN stage_NN 21_CD to_TO stage_VB 29_CD affected_VBD the_DT
        initial_JJ exit_NN of_IN GnRH_NNP neurons_NNS from_IN the_DT OE_NNP and_CC /_NN or_CC their_PRP$ rate_NN
        of_IN migration_NN along_IN the_DT ON_NNP and_CC into_IN the_DT CNS_NNP ._. The_DT second_JJ
        experiments_NNS tested_VBN whether_IN GnRH_NNP neurons_NNS exited_VBD the_DT OE_NNP
        irrespective_RB of_IN the_DT effects_NNS of_IN proteolysis_NNS on_IN the_DT
        maturation_NN of_IN the_DT olfactory_NN nerve_NN ._. In_IN this_DT case_NN
        protein-soaked_JJ beads_NNS were_VBD applied_VBN prior_RB to_TO GnRH_NNP exit_NN (_( stage_NN
        17_CD )_) and_CC the_DT effects_NNS were_VBD tested_VBN at_IN succeeding_VBG stages_NNS up_IN to_TO
        and_CC including_VBG their_PRP$ normal_JJ exit_NN time_NN (_( stages_NNS 18_CD ,_, 19_CD ,_, 20_CD ,_,
        21_CD )_) ._. In_IN the_DT latter_JJ experiments_NNS the_DT effects_NNS of_IN proteolysis_NNS
        and_CC its_PRP$ inhibition_NN on_IN the_DT development_NN of_IN the_DT olfactory_NN
        nerve_NN itself_PRP were_VBD tested_VBN using_VBG axonal_NN ,_, glial_NN and_CC neuronal_NN
        outgrowth_NN markers_NNS ._. These_DT are_VBP the_DT first_JJ experiments_NNS to_TO
        demonstrate_VB the_DT critical_JJ roles_NNS of_IN proteolysis_NNS and_CC its_PRP$
        inhibition_NN on_IN the_DT regulation_NN of_IN GnRH_NNP cellular_JJ
        migration_NN ._.
      
      
        Results_NNS
        
          PN-_NNP 1_CD and_CC trypsin_NN modulate_VBP GnRH_NNP neuronal_NN migration_NN
          in_IN vivo_NN during_IN embryogenesis_NNS
          All_DT embryos_NNS analyzed_VBD were_VBD stage_NN 21_CD at_IN the_DT time_NN of_IN bead_NN
          implantation_NN and_CC stage_NN 29_CD at_IN the_DT time_NN of_IN fixation_NN ._. In_IN
          control_NN embryos_NNS (_( n_NN =_SYM 10_CD )_) receiving_VBG a_DT PB_NNP coated_JJ bead_NN ,_, GnRH_NNP
          neurons_NNS in_IN each_DT compartment_NN were_VBD counted_VBN on_IN the_DT side_NN
          ipsilateral_NN and_CC contralateral_NN to_TO the_DT bead_NN ._. There_EX was_VBD no_DT
          effect_NN of_IN the_DT bead_NN on_IN GnRH_NNP neuronal_NN distribution_NN (_( Table_NNP
          1_LS )_) or_CC total_JJ number_NN (_( Table_NNP 2_LS )_) ._. Sections_NNP counterstained_JJ
          with_IN cresyl_NN violet_NN revealed_VBD no_DT morphological_JJ
          abnormalities_NNS of_IN the_DT epithelium_NN caused_VBN by_IN insertion_NN of_IN
          the_DT bead_NN (_( Figure_NN 1_LS )_) ._.
          In_IN PN-_NNP 1_CD treated_VBN embryos_NNS ,_, the_DT distribution_NN of_IN GnRH_NNP
          neurons_NNS within_IN the_DT olfactory_NN epithelium_NN ,_, nerve_NN and_CC brain_NN
          on_IN the_DT side_NN contralateral_NN to_TO the_DT bead_NN and_CC that_IN of_IN
          controls_NNS were_VBD not_RB significantly_RB different_JJ indicating_VBG that_IN
          the_DT contralateral_NN side_NN in_IN experimental_JJ embryos_NNS served_VBD as_IN
          an_DT internal_JJ control_NN ._. Therefore_RB ,_, statistical_JJ analysis_NN was_VBD
          performed_VBN comparing_VBG values_NNS within_IN embryos_NNS (_( i_NNP ._. e_SYM ._. GnRH_NNP
          neuronal_NN distribution_NN ipsilateral_NN to_TO the_DT bead_NN was_VBD
          compared_VBN to_TO that_DT contralateral_NN to_TO the_DT bead_NN )_) ._.
          Significantly_RB more_JJR neurons_NNS remained_VBD within_IN the_DT epithelium_NN
          (_( P_NN <_NN 0_CD ._. 03_CD )_) and_CC fewer_JJR had_VBD crossed_VBN into_IN the_DT brain_NN (_( P_NN
          <_NN 0_CD ._. 002_CD ,_, see_VBP Table_NNP 1_LS )_) on_IN the_DT PN-_NNP 1_CD treated_VBN side_NN ._. The_DT
          effects_NNS of_IN PN-_NNP 1_CD on_IN GnRH_NNP neuronal_NN distribution_NN cannot_NN be_VB
          attributed_VBN to_TO changes_NNS in_IN total_JJ cell_NN number_NN as_IN there_EX was_VBD
          no_DT difference_NN in_IN this_DT parameter_NN between_IN groups_NNS (_( Table_NNP
          2_LS )_) ._.
          Other_JJ serine_NN protease_NN inhibitors_NNS tested_VBN included_VBD :_:
          soybean_NN trypsin_NN inhibitor_NN and_CC Type_NNP IV_NNP chicken_NN
          ovoinhibitor_NN (_( data_NNS not_RB shown_VBN )_) ._. These_DT protease_NN inhibitors_NNS
          demonstrated_VBD a_DT range_NN of_IN effects_NNS on_IN the_DT distribution_NN of_IN
          GnRH_NNP neurons_NNS across_IN the_DT three_CD compartments_NNS ._. Both_DT
          concentrations_NNS of_IN soybean_NN trypsin_NN inhibitor_NN tested_VBN (_( 1_CD
          mg_NN /_NN ml_NN ,_, n_NN =_SYM 6_CD and_CC 10_CD mg_NN /_NN ml_NN ,_, n_NN =_SYM 4_LS )_) had_VBD no_DT significant_JJ
          effect_NN on_IN the_DT distribution_NN of_IN GnRH_NNP neurons_NNS ._. Application_NNP
          of_IN type_NN IV_NNP chicken_NN ovoinhibitor_NN led_VBN to_TO a_DT decrease_NN in_IN the_DT
          percent_NN of_IN GnRH_NNP neurons_NNS remaining_VBG in_IN the_DT OE_NNP (_( P_NN <_NN 0_CD ._. 02_CD )_)
          and_CC a_DT larger_JJR percent_NN within_IN the_DT telencephalon_NN (_( P_NN <_NN
          0_CD ._. 03_CD )_) ._.
          PN-_NNP 1_CD has_VBZ four_CD known_VBN target_NN proteases_NNS :_: urokinase_NN
          plasminogen_NN activator_NN (_( uPA_NN )_) ,_, tissue_NN type_NN plasminogen_NN
          activator_NN (_( tPA_NN )_) ,_, thrombin_NN and_CC trypsin_NN [_NN 17_CD ]_NN ._. Evidence_NN
          exists_VBZ for_IN a_DT role_NN of_IN both_DT trypsin_NN [_NN 18_CD 19_CD ]_NN and_CC uPA_NN [_NN 20_CD
          21_CD ]_NN in_IN migratory_NN processes_NNS ._. Therefore_RB ,_, both_DT were_VBD tested_VBN
          in_IN our_PRP$ system_NN ._. All_DT comparisons_NNS made_VBN were_VBD of_IN the_DT treated_VBN
          side_NN (_( ipsilateral_NN to_TO the_DT bead_NN )_) and_CC the_DT untreated_JJ side_NN
          (_( contralateral_NN to_TO the_DT bead_NN )_) ._.
          Trypsin_NNP resulted_VBD in_IN fewer_JJR GnRH_NNP neurons_NNS within_IN the_DT
          epithelium_NN (_( P_NN <_NN 0_CD ._. 008_CD )_) and_CC along_IN the_DT olfactory_NN nerve_NN
          (_( P_NN <_NN 0_CD ._. 04_CD )_) and_CC more_JJR within_IN the_DT brain_NN (_( P_NN <_NN 0_CD ._. 0001_CD ,_,
          see_VBP Table_NNP 1_LS )_) ._. There_EX was_VBD no_DT significant_JJ difference_NN in_IN the_DT
          total_JJ number_NN of_IN GnRH_NNP neurons_NNS (_( Table_NNP 2_LS )_) compared_VBN to_TO
          control_VB ._. The_DT effect_NN of_IN trypsin_NN is_VBZ specific_JJ since_IN in_IN
          embryos_NNS receiving_VBG a_DT uPA_NN bead_NN ,_, there_EX was_VBD no_DT effect_NN of_IN the_DT
          protease_NN on_IN the_DT distribution_NN of_IN GnRH_NNP neurons_NNS (_( data_NNS not_RB
          shown_VBN )_) ._.
        
        
          GnRH_NNP neuronal_NN migration_NN is_VBZ cell_NN autonomous_JJ but_CC
          modulated_JJ by_IN composition_NN of_IN the_DT ECM_NNP
          As_IN PN-_NNP 1_CD can_MD stimulate_VB neurite_NN outgrowth_NN ,_, [_NN 2_CD 3_CD 4_CD 5_CD ]_NN
          we_PRP tested_VBD its_PRP$ effects_NNS on_IN outgrowth_NN and_CC maturation_NN of_IN the_DT
          olfactory_NN nerve_NN ._. Maturation_NNP of_IN the_DT nerve_NN was_VBD followed_VBN by_IN
          immunoreactivity_NN to_TO axonal_NN ,_, glial_NN and_CC neuronal_NN markers_NNS
          (_( summarized_VBD in_IN Table_NNP 3_LS )_) ._. All_DT embryos_NNS analyzed_VBD were_VBD stage_NN
          17_CD at_IN the_DT time_NN of_IN bead_NN implantation_NN and_CC stages_NNS 18_CD -_: 21_CD at_IN
          the_DT time_NN of_IN fixation_NN ._.
          Unilateral_NNP insertion_NN of_IN PB_NNP coated_JJ beads_NNS into_IN the_DT
          olfactory_NN placode_NN of_IN stage_NN 17_CD embryos_NNS did_VBD not_RB disrupt_VB the_DT
          development_NN of_IN either_DT axonal_NN or_CC glial_NN components_NNS of_IN the_DT
          olfactory_NN nerve_NN between_IN stages_NNS 18_CD -_: 21_CD (_( Table_NNP 3_LS )_) ._. The_DT time_NN
          of_IN axonal_NN outgrowth_NN and_CC sequential_NN acquisition_NN of_IN axonal_NN
          and_CC glial_NN markers_NNS were_VBD identical_JJ to_TO that_DT observed_VBD
          previously_RB [_NN 15_CD ]_NN ._. The_DT porous_JJ nature_NN of_IN the_DT bead_NN was_VBD
          compatible_JJ with_IN axonal_NN elongation_NN through_IN the_DT mesenchyme_NN
          towards_IN the_DT developing_VBG telencephalic_JJ vesicle_NN ._. In_IN fact_NN ,_,
          immunoreactive_JJ axons_NNS were_VBD found_VBN coursing_VBG through_IN the_DT bead_NN
          (_( Figure_NN 2_LS )_) ._. Likewise_RB ,_, there_EX was_VBD no_DT alteration_NN in_IN the_DT
          timing_NN of_IN GnRH_NNP neuronal_NN migration_NN out_IN of_IN the_DT epithelium_NN ._.
          At_IN stage_NN 21_CD ,_, GnRH_NNP neurons_NNS were_VBD found_VBN within_IN the_DT olfactory_NN
          epithelium_NN and_CC along_IN the_DT olfactory_NN nerve_NN (_( Table_NNP 3_LS )_) ,_, a_DT
          distribution_NN appropriate_JJ for_IN this_DT stage_NN ._.
          Implantation_NNP of_IN PN-_NNP 1_CD beads_NNS did_VBD not_RB stimulate_VB premature_JJ
          olfactory_NN nerve_NN axogenesis_NNS ._. As_IN in_IN controls_NNS ,_, very_RB few_JJ
          MAP_NNP 1_CD b_SYM immunoreactive_JJ neurites_NNS were_VBD present_JJ at_IN stage_NN 18_CD
          (_( Table_NNP 3_LS )_) ._. However_RB ,_, PN-_NNP 1_CD application_NN did_VBD accelerate_VB the_DT
          biochemical_JJ differentiation_NN of_IN the_DT axons_NNS ._. For_IN instance_NN ,_,
          under_IN normal_JJ conditions_NNS ,_, olfactory_NN axons_NNS acquire_VB
          immunoreactivity_NN to_TO NCAM_NNP at_IN stage_NN 20_CD ._. In_IN PN-_NNP 1_CD treated_VBN
          embryos_NNS ,_, NCAM_NNP immunoreactivity_NN was_VBD instead_RB present_JJ at_IN
          stage_NN 19_CD ._. The_DT sequence_NN of_IN appearance_NN of_IN all_DT markers_NNS ,_,
          however_RB ,_, remained_VBD identical_JJ to_TO controls_NNS ._. As_IN the_DT length_NN of_IN
          each_DT developmental_NN stage_NN varies_VBZ [_NN 22_CD ]_NN ,_, it_PRP is_VBZ difficult_JJ
          to_TO determine_VB precisely_RB the_DT amount_NN of_IN time_NN by_IN which_WDT
          biochemical_JJ development_NN of_IN the_DT axons_NNS is_VBZ accelerated_VBN ._. On_IN
          average_JJ ,_, however_RB ,_, biochemical_JJ differentiation_NN is_VBZ advanced_VBN
          by_IN 7_CD hours_NNS ._. Just_RB as_IN PN-_NNP 1_CD did_VBD not_RB alter_VB the_DT timing_NN of_IN
          axogenesis_NNS ,_, it_PRP also_RB had_VBD no_DT effect_NN on_IN the_DT timing_NN of_IN glial_NN
          entry_NN into_IN the_DT nerve_NN (_( stage_NN 21_CD )_) ._. Under_IN these_DT conditions_NNS ,_,
          that_WDT is_VBZ ,_, accelerated_VBN biochemical_JJ differentiation_NN of_IN
          olfactory_NN axons_NNS ,_, GnRH_NNP neuronal_NN distribution_NN was_VBD not_RB
          altered_VBN ._. GnRH_NNP neurons_NNS were_VBD found_VBN within_IN the_DT epithelium_NN
          and_CC along_IN the_DT nerve_NN and_CC ,_, most_RBS importantly_RB ,_, none_NN had_VBD
          crossed_VBN into_IN the_DT brain_NN ._.
          Implantation_NNP of_IN trypsin_NN coated_JJ beads_NNS at_IN stage_NN 17_CD had_VBD
          no_DT effect_NN on_IN either_DT the_DT timing_NN of_IN nerve_NN development_NN
          (_( axonal_NN or_CC glial_NN )_) or_CC the_DT biochemical_JJ differentiation_NN of_IN
          the_DT axons_NNS ._. The_DT distribution_NN of_IN GnRH_NNP neurons_NNS ,_, however_RB ,_, was_VBD
          altered_VBN (_( Table_NNP 3_LS )_) ._. Under_IN normal_JJ conditions_NNS ,_, large_JJ numbers_NNS
          of_IN GnRH_NNP neurons_NNS are_VBP within_IN the_DT telencephalon_NN by_IN
          approximately_RB stage_NN 25_CD ._. In_IN the_DT presence_NN of_IN trypsin_NN ,_,
          however_RB ,_, GnRH_NNP neurons_NNS crossed_VBD the_DT nerve_NN /_NN brain_NN junction_NN at_IN
          stage_NN 21_CD ,_, representing_VBG a_DT significant_JJ acceleration_NN of_IN this_DT
          event_NN ._. Even_RB more_RBR significantly_RB ,_, these_DT cells_NNS had_VBD continued_VBN
          along_IN their_PRP$ normal_JJ migratory_NN path_NN into_IN the_DT presumptive_JJ
          septal_NN and_CC preoptic_JJ areas_NNS ,_, their_PRP$ normal_JJ target_NN sites_NNS ._.
          Application_NNP of_IN uPA_NN beads_NNS at_IN stage_NN 17_CD had_VBD no_DT effect_NN on_IN
          axonogenesis_NNS or_CC the_DT nerve_NN 's_POS biochemical_JJ differentiation_NN
          or_CC glial_NN ensheathment_NN ._. The_DT distribution_NN of_IN GnRH_NNP neurons_NNS
          was_VBD likewise_RB not_RB altered_VBN (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          PN-_NNP 1_CD and_CC trypsin_NN expression_NN along_IN the_DT GnRH_NNP
          migratory_NN route_NN
          Endogenous_NNP trypsin_NN immunoreactivity_NN was_VBD present_JJ in_IN the_DT
          vast_JJ majority_NN of_IN cells_NNS within_IN the_DT head_NN of_IN the_DT chick_NN
          during_IN the_DT time_NN period_NN studied_VBN (_( stage_NN 21_CD -_: 29_CD )_) ._. These_DT cells_NNS
          included_VBD those_DT within_IN the_DT olfactory_NN epithelium_NN and_CC
          throughout_IN the_DT mesenchyme_NN as_RB well_RB as_IN axonal_NN tracts_NNS within_IN
          the_DT developing_VBG face_NN ,_, including_VBG the_DT olfactory_NN nerve_NN
          (_( figure_NN 3_CD ,_, panel_NN A_DT )_) ._. To_TO ensure_VB that_IN the_DT immunoreactivity_NN
          we_PRP see_VBP in_IN chick_NN is_VBZ specific_JJ ,_, trypsin_NN protein_NN was_VBD
          pre-adsorbed_JJ with_IN the_DT anti-trypsin_JJ antibody_NN ._. This_DT complex_NN
          was_VBD then_RB used_VBN to_TO immunostain_NN chick_NN sections_NNS (_( stages_NNS
          21_CD -_: 23_CD )_) ._. No_DT immunoreactivity_NN was_VBD evident_JJ suggesting_VBG that_IN
          the_DT staining_VBG pattern_NN seen_VBN in_IN the_DT chick_NN using_VBG the_DT
          anti-trypsin_JJ antibody_NN was_VBD specific_JJ (_( figure_NN 3_CD ,_, panel_NN B_NNP )_) ._.
          Unlike_IN trypsin_NN ,_, no_DT immunoreactive_JJ uPA_NN was_VBD present_JJ within_IN
          regions_NNS of_IN the_DT olfactory_NN system_NN or_CC the_DT developing_VBG
          telencephalic_JJ vesicle_NN during_IN this_DT time_NN frame_NN (_( data_NNS not_RB
          shown_VBN )_) ._.
          Antibodies_NNP that_WDT recognize_VBP chick_NN PN-_NNP 1_CD are_VBP not_RB available_JJ
          and_CC thus_RB this_DT protease_NN inhibitor_NN was_VBD localized_JJ using_VBG
          mouse_NN embryonic_JJ tissue_NN at_IN developmental_NN times_NNS
          corresponding_JJ to_TO the_DT chick_NN stages_NNS 21_CD -_: 29_CD ._. Double_RB confocal_NN
          immunofluoresence_NN of_IN mouse_NN tissue_NN (_( embryonic_JJ day_NN 15_CD ,_, El_NNP
          5_LS )_) demonstrated_VBN that_IN MAP_NNP 1_CD b_SYM immunoreactive_JJ axons_NNS of_IN the_DT
          vomeronasal_NN nerve_NN (_( VNN_NNP )_) ,_, the_DT highway_NN for_IN GnRH_NNP neurons_NNS in_IN
          the_DT mouse_NN [_NN 11_CD 13_CD ]_NN express_VB PN-_NNP 1_CD protein_NN (_( Figure_NN 4_LS )_) but_CC
          not_RB trypsin_NN (_( data_NNS not_RB shown_VBN )_) ._. Importantly_NNP ,_, PN-_NNP 1_CD
          immunoreactivity_NN was_VBD not_RB limited_VBN to_TO MAP_NNP 1_CD b_SYM immunoreactive_JJ
          axons_NNS ,_, but_CC was_VBD also_RB present_JJ within_IN the_DT basal_NN laminae_NN of_IN
          the_DT vomeronasal_NN organ_NN (_( VNO_NNP )_) as_RB well_RB as_IN within_IN the_DT
          adjacent_JJ mesenchyme_NN (_( Figure_NN 4_LS )_) ._. In_IN both_DT El_NNP 5_CD and_CC adult_NN
          mouse_NN brains_NNS ,_, PN-_NNP 1_CD immunoreactivity_NN within_IN the_DT olfactory_NN
          bulb_NN was_VBD diffuse_NN but_CC appeared_VBD to_TO be_VB more_RBR concentrated_JJ
          within_IN the_DT glomerular_NN layer_NN (_( data_NNS not_RB shown_VBN )_) ._. S_NNP 100_CD
          positive_JJ glia_NN of_IN the_DT VNN_NNP express_VB trypsin_NN (_( Figure_NN 5_LS )_)
          within_IN the_DT cell_NN bodies_NNS and_CC along_IN major_JJ processes_VBZ ;_: the_DT
          diffuse_NN staining_VBG suggested_VBN it_PRP was_VBD also_RB in_IN the_DT matrix_NN of_IN
          the_DT VNN_NNP (_( Figure_NN 5_CD ,_, 5_CD B_NNP )_) ._. It_PRP is_VBZ clear_JJ that_IN PN-_NNP 1_CD protein_NN was_VBD
          not_RB present_JJ in_IN the_DT same_JJ structures_NNS as_IN those_DT
          immunoreactive_JJ for_IN trypsin_NN (_( Figure_NN 6_CD )_) or_CC GnRH_NNP (_( data_NNS not_RB
          shown_VBN )_) ._.
        
      
      
        Discussion_NNP
        This_DT is_VBZ the_DT first_JJ report_NN in_IN which_WDT the_DT 
        in_IN vivo_NN application_NN of_IN a_DT serine_NN
        protease_NN or_CC its_PRP$ inhibitor_NN have_VBP been_VBN demonstrated_VBN to_TO affect_VB
        embryonic_JJ neuronal_NN migration_NN ._. Our_PRP$ data_NNS demonstrate_VBP stage_NN
        specific_JJ effects_NNS of_IN PN-_NNP 1_CD and_CC trypsin_NN on_IN the_DT distribution_NN of_IN
        chick_NN GnRH_NNP neurons_NNS along_IN their_PRP$ migratory_NN route_NN ,_, without_IN an_DT
        alteration_NN of_IN their_PRP$ total_JJ population_NN ._.
        Stage_NN specific_JJ introduction_NN of_IN these_DT proteins_NNS was_VBD via_IN
        unilateral_JJ insertion_NN (_( into_IN either_DT the_DT olfactory_NN epithelium_NN
        or_CC placode_NN )_) of_IN protein_NN coated_JJ Affigel_NNP Blue_NNP beads_NNS ._. The_DT use_NN
        of_IN these_DT beads_NNS is_VBZ an_DT established_VBN method_NN widely_RB utilized_JJ to_TO
        deliver_VB exogenous_JJ proteins_NNS during_IN development_NN ._. For_IN example_NN ,_,
        in_IN their_PRP$ study_NN of_IN limb_NN development_NN ,_, Fallon_NNP 
        et_CC al_NN ._. [_NN 23_CD ]_NN demonstrated_VBD depletion_NN
        of_IN iodinated_JJ FGF_NNP protein_NN from_IN Affigel_NNP Blue_NNP beads_NNS indicating_VBG
        protein_NN does_VBZ indeed_RB diffuse_NN out_IN of_IN the_DT bead_NN ._. In_IN fact_NN ,_, the_DT
        authors_NNS demonstrated_VBN that_IN approximately_RB half_PDT the_DT iodinated_JJ
        protein_NN diffused_JJ off_IN the_DT bead_NN within_IN the_DT first_JJ 24_CD hours_NNS and_CC
        70_CD %_NN diffused_JJ by_IN approximately_RB 60_CD hours_NNS ._. These_DT data_NNS indicate_VBP
        that_DT protein_NN is_VBZ present_JJ and_CC diffusing_VBG into_IN the_DT surrounding_VBG
        area_NN up_IN to_TO 60_CD hours_NNS following_VBG implantation_NN of_IN the_DT bead_NN ._. Our_PRP$
        experiments_NNS were_VBD carried_VBN out_IN within_IN this_DT window_NN of_IN time_NN
        (_( there_EX are_VBP 24_CD hours_NNS between_IN stage_NN 17_CD to_TO 21_CD and_CC 60_CD hours_NNS
        between_IN stage_NN 21_CD and_CC 29_CD )_) ._. In_IN addition_NN ,_, subsequent_JJ studies_NNS
        examining_VBG the_DT roles_NNS of_IN BMP_NN ,_, FGF_NNP 's_POS and_CC Shh_NNP have_VBP also_RB
        utilized_JJ Affigel_NNP Blue_NNP beads_NNS to_TO exogenously_RB introduce_VB
        various_JJ protein_NN components_NNS [_NN 24_CD 25_CD ]_NN ._. The_DT results_NNS of_IN these_DT
        studies_NNS have_VBP been_VBN consistent_JJ with_IN the_DT known_VBN temporal_JJ and_CC
        spatial_NN distributions_NNS of_IN these_DT proteins_NNS ._.
        Modification_NNP of_IN the_DT extracellular_NN milieu_NN via_IN local_JJ
        shifts_NNS in_IN the_DT protease_NN /_NN inhibitor_NN balance_NN may_MD regulate_VB
        neuronal_NN migration_NN ._. This_DT hypothesis_NNS is_VBZ supported_VBN by_IN our_PRP$
        findings_NNS on_IN stage_NN 21_CD -_: 29_CD embryos_NNS ._. In_IN these_DT experiments_NNS ,_,
        inhibition_NN of_IN endogenous_JJ trypsin-like_JJ activity_NN by_IN PN-_NNP 1_CD
        resulted_VBD in_IN fewer_JJR GnRH_NNP neurons_NNS exiting_VBG the_DT olfactory_NN
        epithelium_NN and_CC a_DT corresponding_JJ decrease_NN in_IN the_DT number_NN
        entering_VBG the_DT brain_NN ._. Conversely_RB ,_, increasing_VBG trypsin_NN
        availability_NN promoted_VBD neuronal_NN crossing_VBG of_IN these_DT two_CD
        boundary_NN zones_NNS ._. We_PRP hypothesize_NN that_IN the_DT serine_NN
        protease_NN /_NN inhibitor_NN pair_NN act_NN by_IN altering_VBG the_DT ECM_NNP through_IN
        which_WDT GnRH_NNP neurons_NNS migrate_VB ._. Matrix_NNP involvement_NN in_IN migration_NN
        is_VBZ supported_VBN by_IN the_DT identification_NN of_IN matrix_NN components_NNS
        throughout_IN the_DT GnRH_NNP migratory_NN route_NN ._. At_IN the_DT epithelium_NN ,_,
        GnRH_NNP neurons_NNS cross_VBP the_DT basal_NN laminae_NN to_TO initiate_VB their_PRP$
        migratory_NN phase_NN [_NN 15_CD ]_NN ._. The_DT olfactory_NN nerve_NN expresses_VBZ
        several_JJ matrix_NN molecules_NNS [_NN heparan_NN and_CC keratan_NN sulfate_NN
        proteoglycans_NNS [_NN 26_CD ]_NN ,_, laminin_NN [_NN 27_CD ]_NN ,_, phosphocan_NN [_NN 28_CD ]_NN ,_,
        lectin-binding_JJ domains_NNS [_NN 29_CD ]_NN ]_NN ._. Any_DT or_CC all_DT of_IN these_DT may_MD
        serve_VB as_IN substrates_NNS for_IN proteolysis_NNS ._. The_DT three_CD domains_NNS ,_, the_DT
        olfactory_NN epithelium_NN ,_, olfactory_NN nerve_NN and_CC the_DT brain_NN ,_,
        represent_VB regulatory_JJ road_NN blocks_NNS to_TO the_DT GnRH_NNP cell_NN ._. By_IN
        inhibiting_VBG local_JJ proteolysis_NNS ,_, PN-_NNP 1_CD produces_VBZ a_DT non-conducive_JJ
        environment_NN at_IN these_DT points_NNS ._. Likewise_RB ,_, promotion_NN of_IN local_JJ
        proteolysis_NNS by_IN trypsin_NN ,_, results_NNS in_IN a_DT permissive_JJ migratory_NN
        environment_NN ._.
        Though_IN modification_NN of_IN the_DT ECM_NNP composition_NN may_MD indeed_RB
        explain_VB the_DT data_NNS ,_, another_DT explanation_NN may_MD lie_VB in_IN the_DT
        activation_NN /_NN inhibition_NN of_IN protease_NN activated_VBN receptors_NNS
        (_( PAR_NNP 's_POS )_) ._. These_DT two_CD hypotheses_NNS are_VBP not_RB mutually_RB exclusive_JJ
        but_CC rather_RB may_MD work_VB in_IN concert_NN to_TO regulate_VB neuronal_NN
        migration_NN ._. PAR_NNP 'S_VBZ are_VBP G-_NNP coupled_VBN receptors_NNS activated_VBN by_IN
        proteolytic_JJ cleavage_NN of_IN their_PRP$ exo-domains_JJ ._. This_DT cleavage_NN
        exposes_NNS an_DT amino_JJ acid_NN sequence_NN which_WDT then_RB serves_VBZ as_IN a_DT
        tethered_JJ ligand_NN activating_VBG transmembrane_NN signaling_VBG ._. Four_CD
        PAR_NNP 'S_VBZ have_VBP been_VBN identified_VBN (_( PAR_NNP 1_CD -_: 4_LS )_) ;_: PAR_NNP 'S_VBZ 1_CD ,_, 3_CD and_CC 4_CD are_VBP
        activated_VBN by_IN thrombin_NN while_IN PAR_NNP 2_CD is_VBZ activated_VBN by_IN trypsin_NN [_NN
        30_CD ]_NN ._. Activation_NNP of_IN PAR_NNP 'S_VBZ may_MD alter_VB ECM_NNP composition_NN ._. For_IN
        example_NN ,_, Hattori_NNP 
        et_CC al_NN ._. [_NN 31_CD ]_NN demonstrated_VBN that_DT
        thrombin_NN activation_NN of_IN PAR_NNP 1_CD led_VBN to_TO deposition_NN of_IN
        P-_NNP selectin_NN ,_, a_DT leukocyte_NN adhesion_NN molecule_NN ,_, on_IN the_DT surfaces_VBZ
        of_IN endothelial_NN cells_NNS ._. This_DT change_NN in_IN matrix_NN composition_NN
        allows_VBZ for_IN leukocyte_NN attachment_NN and_CC subsequent_JJ infiltration_NN
        of_IN the_DT endothelium_NN ._. PAR_NNP 'S_VBZ are_VBP expressed_VBN in_IN the_DT developing_VBG
        rat_NN CNS_NNP [_NN 32_CD ]_NN as_RB well_RB as_IN in_IN the_DT embryonic_JJ chick_NN [_NN 33_CD ]_NN ._.
        Though_IN we_PRP did_VBD not_RB localize_NN PAR_NNP expression_NN in_IN our_PRP$ model_NN
        system_NN ,_, it_PRP remains_VBZ a_DT possibility_NN that_IN their_PRP$ activation_NN or_CC
        inhibition_NN may_MD modulate_VBP the_DT ECM_NNP composition_NN and_CC thus_RB GnRH_NNP
        neuronal_NN migration_NN ._.
        The_DT fact_NN that_IN mammalian_JJ PN-_NNP 1_CD alters_NNS neuronal_NN migration_NN
        in_IN an_DT avian_NN species_NNS suggests_VBZ the_DT presence_NN of_IN endogenous_JJ
        serine_NN protease_NN activity_NN in_IN the_DT region_NN ._. Such_JJ a_DT protease_NN ,_,
        with_IN trypsin-like_JJ immunoreactivity_NN ,_, was_VBD detected_VBN by_IN
        immunocytochemistry_NN ._. To_TO biochemically_RB characterize_VB this_DT
        endogenous_JJ activity_NN ,_, non-neurally_JJ derived_VBN trypsin_NN
        inhibitors_NNS were_VBD tested_VBN ._. At_IN the_DT concentrations_NNS tested_VBN ,_,
        soybean_NN trypsin_NN inhibitor_NN had_VBD no_DT effect_NN on_IN GnRH_NNP migration_NN ._.
        These_DT results_NNS could_MD be_VB due_JJ to_TO differences_NNS in_IN binding_JJ
        affinity_NN between_IN soybean_NN trypsin_NN inhibitor_NN and_CC PN-_NNP 1_CD for_IN the_DT
        endogenous_JJ trypsin-like_JJ molecule_NN ._. The_DT inhibition_NN of_IN
        trypsin-like_JJ proteases_NNS by_IN different_JJ inhibitors_NNS (_( including_VBG
        PN-_NNP 1_CD and_CC soybean_NN trypsin_NN inhibitor_NN )_) varies_VBZ widely_RB and_CC a_DT
        lack_NN of_IN an_DT effect_NN is_VBZ not_RB uncommon_JJ (_( e_SYM ._. g_SYM ._. 34_CD )_) ._.
        Contrary_JJ to_TO the_DT effect_NN seen_VBN with_IN PN-_NNP 1_CD ,_, type_NN IV_NNP chick_NN
        ovoinhibitor_NN accelerated_VBD neuronal_NN migration_NN with_IN fewer_JJR GnRH_NNP
        neurons_NNS in_IN the_DT epithelium_NN and_CC correspondingly_RB more_JJR within_IN
        the_DT brain_NN ._. At_IN least_JJS two_CD mechanisms_NNS can_MD explain_VB this_DT result_NN ._.
        First_LS ,_, type_NN IV_NNP chick_NN ovoinhibitor_NN may_MD not_RB be_VB acting_VBG as_IN an_DT
        inhibitor_NN in_IN our_PRP$ system_NN as_IN it_PRP has_VBZ been_VBN demonstrated_VBN to_TO be_VB
        ineffective_JJ in_IN other_JJ systems_NNS [_NN 34_CD 35_CD 36_CD ]_NN ._. Alternatively_RB ,_,
        if_IN it_PRP is_VBZ serving_VBG as_IN a_DT protease_NN inhibitor_NN ,_, it_PRP may_MD inactivate_NN
        a_DT molecule_NN different_JJ from_IN that_DT affected_VBN by_IN PN-_NNP 1_CD and_CC ,_, in_IN
        doing_VBG so_RB ,_, generate_VBP an_DT environment_NN permissive_JJ for_IN neuronal_NN
        migration_NN ._.
        Both_DT non-neuronally_JJ derived_VBN trypsin_NN inhibitors_NNS tested_VBN
        yielded_VBD results_NNS different_JJ from_IN that_DT of_IN PN-_NNP 1_CD suggesting_VBG they_PRP
        possess_VBP different_JJ protease_NN specificities_NNS ,_, affinities_NNS ,_, or_CC
        functions_NNS ._. Regardless_RB of_IN their_PRP$ mechanisms_NNS of_IN action_NN ,_, these_DT
        data_NNS support_VBP the_DT hypothesis_NNS that_IN changes_NNS in_IN enzymatic_JJ
        activities_NNS can_MD influence_VB neuronal_NN migration_NN ._.
        In_IN contrast_NN to_TO PN-_NNP 1_CD ,_, trypsin_NN leads_VBZ to_TO a_DT permissive_JJ
        environment_NN during_IN this_DT developmental_NN period_NN (_( stages_NNS 21_CD -_: 29_CD )_)
        resulting_VBG in_IN a_DT global_JJ acceleration_NN of_IN GnRH_NNP neuronal_NN
        migration_NN out_IN of_IN the_DT olfactory_NN epithelium_NN and_CC into_IN the_DT
        brain_NN ._. Trypsin_NNP cleaves_NNS peptide_NN bonds_NNS at_IN the_DT carboxyl_NN side_NN
        of_IN either_DT arginine_NN or_CC lysine_NN residues_NNS ._. This_DT rather_RB
        non-specific_JJ cleavage_NN suggests_VBZ trypsin_NN may_MD alter_VB many_JJ
        different_JJ components_NNS of_IN the_DT ECM_NNP which_WDT themselves_PRP vary_VBP in_IN
        each_DT compartment_NN ._. Interestingly_RB ,_, in_IN the_DT chick_NN ,_, trypsin_NN
        immunoreactivity_NN was_VBD present_JJ throughout_IN the_DT head_NN as_RB well_RB as_IN
        in_IN the_DT olfactory_NN nerve_NN ._. This_DT ubiquitous_JJ distribution_NN
        suggests_VBZ that_IN the_DT specificity_NN of_IN the_DT protease_NN /_NN inhibitor_NN
        system_NN may_MD be_VB imparted_JJ by_IN an_DT avian_NN equivalent_NN of_IN PN-_NNP 1_CD ._.
        We_PRP found_VBD no_DT effect_NN on_IN GnRH_NNP neuronal_NN distribution_NN in_IN
        uPA-treated_JJ embryos_NNS and_CC no_DT uPA_NN immunoreactivity_NN ._. This_DT
        result_NN is_VBZ not_RB surprising_JJ in_IN light_NN of_IN a_DT study_NN by_IN Del_NNP Bigio_NNP 
        et_CC al_NN ._. [_NN 37_CD ]_NN in_IN which_WDT the_DT expression_NN
        pattern_NN of_IN uPA_NN was_VBD analyzed_VBN in_IN the_DT postnatal_NN mouse_NN ._. Based_VBN
        on_IN its_PRP$ spatio-temporal_JJ expression_NN pattern_NN ,_, the_DT authors_NNS
        concluded_VBD that_DT uPA_NN may_MD function_VB in_IN processes_NNS of_IN
        synaptogenesis_NNS and_CC remodeling_VBG rather_RB than_IN in_IN cell_NN
        migration_NN ._. In_IN addition_NN ,_, our_PRP$ data_NNS indicate_VBP that_IN simply_RB
        coating_NN beads_NNS with_IN any_DT serine_NN protease_NN is_VBZ not_RB sufficient_JJ to_TO
        influence_VB migration_NN ._. Thus_RB ,_, not_RB only_RB is_VBZ our_PRP$ experimental_JJ
        approach_NN unbiased_JJ ,_, but_CC the_DT antagonistic_JJ relationship_NN of_IN
        PN-_NNP 1_CD and_CC trypsin_NN on_IN GnRH_NNP neuronal_NN migration_NN is_VBZ
        specific_JJ ._.
        A_DT PN-_NNP 1_CD specific_JJ antibody_NN that_DT cross_NN reacts_VBZ with_IN chick_NN
        tissue_NN is_VBZ not_RB available_JJ ,_, thus_RB we_PRP were_VBD unable_JJ to_TO follow_VB its_PRP$
        expression_NN in_IN the_DT chick_NN ._. Although_IN avian_NN and_CC mammalian_JJ
        serpins_NNS are_VBP members_NNS of_IN the_DT same_JJ superfamily_RB ,_, they_PRP are_VBP
        evolutionarily_RB distinct_JJ [_NN 38_CD ]_NN ._. This_DT divergence_NN likely_JJ
        accounts_NNS for_IN the_DT species_NNS specificity_NN of_IN the_DT PN-_NNP 1_CD antibody_NN ._.
        To_TO determine_VB whether_IN PN-_NNP 1_CD is_VBZ expressed_VBN by_IN the_DT olfactory_NN
        system_NN during_IN the_DT time_NN of_IN active_JJ GnRH_NNP neuronal_NN migration_NN ,_,
        we_PRP examined_VBD its_PRP$ expression_NN in_IN the_DT embryonic_JJ mouse_NN where_WRB its_PRP$
        mRNA_NN is_VBZ known_VBN to_TO be_VB expressed_VBN [_NN 39_CD ]_NN ._. At_IN E_NNP 15_CD ,_, PN-_NNP 1_CD protein_NN
        is_VBZ present_JJ within_IN MAP_NNP 1_CD b_SYM immunoreactive_JJ axons_NNS of_IN the_DT
        vomeronasal_NN nerve_NN (_( the_DT migratory_NN path_NN used_VBN by_IN GnRH_NNP neurons_NNS
        in_IN mammals_NNS )_) ._. PN-_NNP 1_CD immunoreactivity_NN was_VBD also_RB present_JJ within_IN
        the_DT basal_NN laminae_NN of_IN the_DT vomeronasal_NN organ_NN ,_, a_DT barrier_NN
        crossed_VBN by_IN GnRH_NNP neurons_NNS when_WRB they_PRP initiate_VBP their_PRP$ migration_NN ._.
        This_DT staining_VBG pattern_NN ,_, along_IN with_IN our_PRP$ data_NNS on_IN PN-_NNP 1_CD 's_POS effect_NN
        on_IN migration_NN ,_, strengthens_VBZ our_PRP$ hypothesis_NNS that_IN this_DT serine_NN
        protease_NN inhibitor_NN plays_VBZ a_DT role_NN in_IN neuronal_NN migration_NN ._. In_IN
        addition_NN ,_, expression_NN of_IN other_JJ serine_NN protease_NN inhibitors_NNS
        has_VBZ been_VBN described_VBN in_IN other_JJ migrating_VBG neurons_NNS ._. For_IN example_NN ,_,
        Krueger_NNP 
        et_CC al_NN ._. [_NN 40_CD ]_NN demonstrated_VBN increased_VBN
        expression_NN of_IN neuroserpin_NN within_IN migrating_VBG granule_NN cells_NNS of_IN
        the_DT cerebellum_NN in_IN the_DT post_NN natal_NN mouse_NN ._.
        In_IN the_DT mouse_NN ,_, trypsin_NN immunoreactivity_NN is_VBZ present_JJ within_IN
        S_NNP 100_CD immunoreactive_JJ glia_NN which_WDT ensheath_NN axons_NNS of_IN the_DT
        vomeronasal_NN nerve_NN ._. As_IN with_IN PN-_NNP 1_CD ,_, it_PRP is_VBZ also_RB present_JJ in_IN the_DT
        extracellular_NN matrix_NN where_WRB it_PRP is_VBZ likely_JJ that_IN the_DT
        protease_NN /_NN inhibitor_NN pair_NN function_NN to_TO regulate_VB ,_, at_IN least_JJS in_IN
        part_NN ,_, the_DT environment_NN through_IN which_WDT GnRH_NNP neurons_NNS
        migrate_VB ._.
        Due_JJ to_TO its_PRP$ ability_NN to_TO stimulate_VB neurite_NN outgrowth_NN ,_, we_PRP
        asked_VBD whether_IN PN-_NNP 1_CD could_MD alter_VB the_DT timing_NN of_IN formation_NN of_IN
        the_DT olfactory_NN nerve_NN and_CC if_IN so_RB ,_, what_WP effect_NN this_DT might_MD have_VB
        on_IN GnRH_NNP neuronal_NN migration_NN ._. For_IN these_DT experiments_NNS ,_, bead_NN
        implantation_NN into_IN the_DT olfactory_NN placode_NN was_VBD performed_VBN at_IN
        stage_NN 17_CD just_RB prior_RB to_TO olfactory_NN nerve_NN axonogenesis_NNS ._. PN-_NNP 1_CD
        did_VBD not_RB accelerate_VB neurite_NN outgrowth_NN but_CC did_VBD accelerate_VB
        detectable_JJ levels_NNS of_IN biochemical_JJ differentiation_NN markers_NNS of_IN
        the_DT olfactory_NN nerve_NN ._. These_DT data_NNS suggest_VBP that_IN the_DT olfactory_NN
        neurons_NNS can_MD respond_VB to_TO PN-_NNP 1_CD directly_RB or_CC to_TO changes_NNS in_IN the_DT
        local_JJ environment_NN caused_VBN by_IN PN-_NNP 1_CD ._.
        The_DT distribution_NN of_IN GnRH_NNP neurons_NNS was_VBD not_RB altered_VBN by_IN PN-_NNP 1_CD
        at_IN stages_NNS 17_CD -_: 21_CD in_IN spite_NN of_IN the_DT accelerated_VBN maturation_NN of_IN
        the_DT olfactory_NN nerve_NN ._. Likewise_RB ,_, PN-_NNP 1_CD did_VBD not_RB alter_VB the_DT
        timing_NN of_IN the_DT nerve_NN 's_POS ensheathment_NN by_IN glia_NN ._. This_DT suggests_VBZ
        that_DT glial_NN migration_NN is_VBZ independent_JJ of_IN any_DT matrix_NN changes_NNS
        induced_VBN by_IN PN-_NNP 1_CD ._. The_DT fact_NN that_IN GnRH_NNP neurons_NNS and_CC the_DT glial_NN
        ensheathing_VBG cells_NNS exit_NN at_IN the_DT same_JJ time_NN (_( stage_NN 21_CD )_) may_MD be_VB
        coincidental_JJ or_CC may_MD be_VB due_JJ to_TO an_DT interaction_NN between_IN these_DT
        two_CD populations_NNS ._. Alternatively_RB ,_, the_DT timing_NN of_IN exit_NN of_IN GnRH_NNP
        neurons_NNS and_CC glia_NN may_MD be_VB cell-autonomous_JJ events_NNS ._.
        Implantation_NNP of_IN a_DT trypsin_NN bead_NN at_IN stage_NN 17_CD had_VBD no_DT effect_NN
        on_IN the_DT biochemical_JJ maturation_NN of_IN the_DT olfactory_NN nerve_NN nor_CC on_IN
        the_DT timing_NN of_IN glial_NN or_CC GnRH_NNP neuronal_NN migration_NN ._. At_IN this_DT
        early_JJ stage_NN ,_, at_IN least_JJS some_DT of_IN the_DT barriers_NNS to_TO GnRH_NNP neuronal_NN
        exit_NN from_IN the_DT epithelium_NN are_VBP in_IN place_NN [_NN 15_CD ]_NN ._. Therefore_RB ,_,
        the_DT lack_NN of_IN an_DT effect_NN on_IN migration_NN by_IN trypsin_NN suggests_VBZ that_IN
        the_DT initiation_NN of_IN migration_NN is_VBZ an_DT inherent_JJ property_NN of_IN the_DT
        GnRH_NNP neuron_NN (_( and_CC glial_NN cell_NN )_) ._. At_IN stage_NN 21_CD ,_, however_RB ,_, trypsin_NN
        did_VBD significantly_RB alter_VB the_DT distribution_NN of_IN GnRH_NNP neurons_NNS
        such_JJ that_IN a_DT large_JJ population_NN was_VBD already_RB in_IN the_DT brain_NN ._.
        These_DT neurons_NNS not_RB only_RB entered_VBD the_DT brain_NN early_JJ but_CC also_RB
        traveled_VBD caudalward_NN within_IN the_DT brain_NN along_IN their_PRP$ normal_JJ
        arching_VBG trajectory_NN ._.
        Taken_VBN together_RB ,_, these_DT data_NNS suggest_VBP that_IN in_IN the_DT presence_NN
        of_IN either_DT trypsin_NN or_CC PN-_NNP 1_CD (_( at_IN stage_NN 17_CD )_) ,_, GnRH_NNP neurons_NNS exit_NN
        the_DT olfactory_NN epithelium_NN at_IN stage_NN 21_CD ,_, as_IN in_IN controls_NNS ._.
        Therefore_RB ,_, the_DT ability_NN to_TO initiate_VB migration_NN resides_VBZ within_IN
        the_DT neuron_NN itself_PRP such_JJ that_IN alterations_NNS of_IN ECM_NNP composition_NN
        during_IN this_DT time_NN (_( stage_NN 17_CD -_: 21_CD )_) are_VBP irrelevant_JJ to_TO the_DT timing_NN
        of_IN this_DT initial_JJ event_NN ._. The_DT finding_VBG that_IN the_DT neurons_NNS enter_VBP
        the_DT CNS_NNP early_RB in_IN trypsin-treated_JJ embryos_NNS suggests_VBZ that_WDT
        continued_JJ movement_NN may_MD be_VB a_DT cell_NN autonomous_JJ event_NN with_IN
        trypsin-induced_JJ proteolysis_NNS generating_VBG a_DT permissive_JJ
        environment_NN ._. Finally_RB ,_, these_DT data_NNS demonstrate_VBP that_IN the_DT GnRH_NNP
        neuron_NN 's_POS ability_NN to_TO transit_NN across_IN the_DT glia_NN limitans_NNS and_CC
        through_IN the_DT brain_NN to_TO its_PRP$ target_NN sites_NNS is_VBZ independent_JJ of_IN
        additional_JJ maturation_NN of_IN the_DT neuron_NN itself_PRP ,_, the_DT olfactory_NN
        nerve_NN or_CC the_DT brain_NN ._.
        Our_PRP$ data_NNS support_VBP a_DT role_NN of_IN proteases_NNS and_CC their_PRP$
        inhibitors_NNS in_IN neuronal_NN migration_NN ._. The_DT complex_JJ interactions_NNS
        between_IN a_DT neuron_NN and_CC its_PRP$ environment_NN are_VBP likely_JJ not_RB
        regulated_VBN by_IN proteolysis_NNS alone_RB ._. The_DT characteristic_JJ directed_VBN
        migratory_NN pattern_NN taken_VBN by_IN the_DT GnRH_NNP neuron_NN and_CC the_DT
        cohesiveness_NNS of_IN the_DT population_NN suggests_VBZ a_DT more_RBR complex_JJ
        system_NN is_VBZ in_IN place_NN to_TO ensure_VB their_PRP$ appropriate_JJ
        translocation_NN into_IN the_DT brain_NN ._. In_IN fact_NN ,_, Kramer_NNP and_CC Wray_NNP [_NN 42_CD
        ]_NN have_VBP identified_VBN a_DT novel_NN gene_NN ,_, nasal_NN embryonic_JJ LHRH_NNP (_( GnRH_NNP )_)
        factor_NN or_CC NELF_NNP ,_, which_WDT is_VBZ expressed_VBN by_IN GnRH_NNP neurons_NNS during_IN
        their_PRP$ migratory_NN phase_NN and_CC olfactory_NN sensory_JJ neurons_NNS as_IN they_PRP
        initiate_VBP axonogenesis_NNS ._. Antisense_NNP depletion_NN of_IN NELF_NNP led_VBD to_TO a_DT
        decrease_NN in_IN both_DT olfactory_NN axonal_NN outgrowth_NN and_CC the_DT number_NN
        of_IN GnRH_NNP neurons_NNS exiting_VBG the_DT epithelium_NN ._. The_DT authors_NNS suggest_VBP
        that_IN NEFL_NNP may_MD function_VB as_IN a_DT migratory_NN factor_NN ._. It_PRP seems_VBZ
        likely_JJ therefore_RB that_IN several_JJ components_NNS interact_NN to_TO
        orchestrate_NN the_DT proper_JJ migration_NN of_IN neurons_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Animal_NNP and_CC tissue_NN preparation_NN
          
            Chicks_NNP
            Fertilized_NNP eggs_NNS (_( white_JJ leghorn_NN ,_, SPAFAS_NNP ,_, Preston_NNP ,_, CT_NNP )_)
            were_VBD placed_VBN in_IN an_DT incubator_NN (_( Humidaire_NNP Incubator_NNP ,_, Co_NNP ._.
            New_NNP Madison_NNP ,_, OH_NNP )_) at_IN 99_CD ._. 5_LS °_NN C_NNP and_CC 85_CD %_NN relative_JJ humidity_NN ._. A_DT
            window_NN was_VBD cut_VBN in_IN each_DT shell_NN to_TO determine_VB the_DT
            developmental_NN stage_NN of_IN each_DT embryo_NN [_NN 22_CD ]_NN ._. To_TO
            visualize_VB the_DT extraembryonic_JJ membranes_NNS ,_, Fast_NNP Green_NNP
            (_( 1_CD :_: 10_CD ,_, 000_CD Molecular_NNP Probes_NNP ,_, Eugene_NNP ,_, OR_NNP )_) was_VBD applied_VBN to_TO
            the_DT surface_NN of_IN the_DT embryo_NN and_CC membranes_NNS were_VBD teased_VBN
            apart_RB using_VBG forceps_NNS ._. Appropriately_NNP sized_VBD Affigel_NNP Blue_NNP
            beads_NNS (_( BioRad_NNP ,_, Hercules_NNP ,_, CA_NNP )_) were_VBD unilaterally_RB inserted_VBN
            either_CC into_IN the_DT olfactory_NN placode_NN (_( stage_NN 17_CD )_) or_CC the_DT
            olfactory_NN epithelium_NN (_( stage_NN 21_CD )_) and_CC the_DT egg_NN was_VBD
            returned_VBN to_TO the_DT incubator_NN until_IN time_NN of_IN fixation_NN ._.
            Control_NN animals_NNS were_VBD implanted_VBN with_IN beads_NNS coated_VBN with_IN
            0_CD ._. 1_CD M_NNP phosphate_NN buffer_NN ,_, pH_NN 7_CD ._. 3_CD (_( PB_NNP ,_, N_NNP =_SYM 10_CD )_) ._.
            Experimental_NNP embryos_NNS were_VBD implanted_VBN with_IN beads_NNS coated_VBN
            with_IN PN-_NNP 1_CD bead_NN (_( N_NNP =_SYM 12_CD )_) or_CC trypsin_NN (_( N_NNP =_SYM 11_CD )_) ._. Embryos_NNP
            receiving_VBG a_DT bead_NN at_IN stage_NN 17_CD were_VBD fixed_VBN at_IN stage_NN 18_CD (_( N_NNP
            =_SYM 9_CD )_) ,_, stage_NN 19_CD (_( N_NNP =_SYM 16_CD )_) ,_, stage_NN 20_CD (_( N_NNP =_SYM 17_CD )_) or_CC stage_NN 21_CD
            (_( N_NNP =_SYM 9_CD )_) ._. Embryos_NNP receiving_VBG a_DT bead_NN at_IN stage_NN 21_CD ,_, were_VBD
            fixed_VBN at_IN stage_NN 29_CD (_( N_NNP =_SYM 10_CD )_) ._.
            Embryos_NNP were_VBD fixed_VBN by_IN immersion_NN in_IN 4_CD %_NN
            paraformaldehyde_NN (_( Fisher_NNP Scientific_NNP ,_, Pittsburgh_NNP ,_, PA_NNP )_)
            for_IN 1_CD -_: 7_CD days_NNS depending_VBG on_IN the_DT stage_NN (_( younger_JJR embryos_NNS
            required_VBD shorter_JJR fixation_NN times_NNS )_) ._. Fixed_NNP embryos_NNS were_VBD
            embedded_VBN in_IN 8_CD %_NN gelatin_NN and_CC fixed_VBN in_IN 4_CD %_NN
            paraformaldehyde_NN ._. 100_CD μm_NN sagittal_NN sections_NNS were_VBD cut_VBN on_IN
            a_DT vibratome_NN (_( DSK_NNP Microslicer_NNP 1500_CD E_NNP ,_, Ted_NNP Pella_NNP ,_, Inc_NNP ._. ,_,
            Redding_NNP ,_, CA_NNP )_) and_CC immunocytochemistry_NN was_VBD performed_VBN on_IN
            free-floating_JJ sections_NNS ._. Tissue_NNP was_VBD then_RB mounted_VBN onto_IN
            slides_NNS ,_, dehydrated_JJ through_IN graded_JJ alcohols_NNS ,_, cleared_VBD
            with_IN HemoD_NNP (_( Fisher_NNP )_) and_CC coverslipped_JJ with_IN Permount_NNP
            (_( Fisher_NNP )_) ._.
          
          
            Mice_NNS
            As_IN reagents_NNS for_IN the_DT localization_NN of_IN PN-_NNP 1_CD in_IN the_DT
            chick_NN are_VBP not_RB available_JJ ,_, we_PRP examined_VBD its_PRP$ localization_NN
            in_IN the_DT embryonic_JJ mouse_NN at_IN the_DT time_NN of_IN GnRH_NNP migration_NN ._.
            Immunolocalization_NNP of_IN PN-_NNP 1_CD protein_NN was_VBD performed_VBN on_IN
            embryonic_JJ day_NN 15_CD (_( El_NNP 5_CD ,_, day_NN of_IN plug_NN was_VBD considered_VBN
            E_NNP 0_CD ._. 5_LS )_) ._. Swiss_NNP Webster_NNP mice_NNS were_VBD used_VBN (_( Charles_NNP River_NNP ,_,
            Kingston_NNP ,_, MA_NNP )_) ._. Mouse_NNP embryos_NNS (_( N_NNP =_SYM 6_CD )_) and_CC an_DT adult_NN
            female_JJ (_( N_NNP =_SYM 1_LS )_) were_VBD processed_VBN for_IN double_JJ label_NN
            immunofluorescence_NN to_TO determine_VB the_DT cellular_JJ
            localization_NN of_IN PN-_NNP 1_CD and_CC trypsin_NN ._. The_DT mothers_NNS were_VBD
            euthenized_JJ with_IN CO_NNP 
            2_CD and_CC embryos_NNS placed_VBN in_IN PB_NNP and_CC
            decapitated_JJ rapidly_RB ._. The_DT adult_NN was_VBD anesthetized_JJ with_IN
            nembutal_NN (_( 70_CD mg_NN /_NN kg_NN )_) and_CC perfused_JJ transcardially_RB ._. Tissue_NNP
            was_VBD treated_VBN as_IN described_VBN above_IN ._.
          
          
            Anesthesia_NNP ,_, Surgery_NNP ,_, and_CC Perfusion_NNP
            All_DT procedures_NNS for_IN the_DT mice_NNS met_VBD with_IN NIH_NNP guidelines_NNS
            and_CC were_VBD approved_VBN by_IN the_DT Institutional_NNP Animal_NNP Care_NNP and_CC
            Use_NNP Committee_NNP of_IN Columbia_NNP University_NNP ._.
          
        
        
          Affigel-_NNP Blue_NNP bead_NN preparation_NN
          Affigel_NNP Blue_NNP beads_NNS (_( BioRad_NNP ,_, Hercules_NNP ,_, CA_NNP )_) were_VBD sized_VBD
          using_VBG a_DT dissecting_VBG microscope_NN and_CC forceps_NNS as_IN described_VBN by_IN
          Vogel_NNP 
          et_CC al_NN ._. [_NN 41_CD ]_NN ._. Beads_NNP 30_CD -_: 50_CD μm_NN in_IN
          diameter_NN were_VBD used_VBN for_IN stage_NN 21_CD embryos_NNS and_CC beads_NNS 20_CD μm_NN
          in_IN diameter_NN were_VBD used_VBN for_IN stage_NN 17_CD embryos_NNS to_TO accommodate_VB
          the_DT smaller_JJR target_NN area_NN ._. Beads_NNP were_VBD placed_VBN in_IN one_CD of_IN the_DT
          following_JJ solutions_NNS :_: 3_CD ._. 1_CD mg_NN /_NN ml_NN of_IN recombinant_JJ rat_NN PN-_NNP 1_CD ;_:
          2_CD ._. 3_CD mg_NN /_NN ml_NN of_IN trypsin_NN (_( type_NN III_NNP bovine_JJ pancreas_NN ,_, Sigma_NNP ,_,
          St_NNP ._. Louis_NNP ,_, MO_NNP )_) ;_: 1_CD mg_NN /_NN ml_NN urokinase_NN plasminogen_NN activator_NN
          (_( uPA_NN ,_, Sigma_NNP ,_, St_NNP Louis_NNP ,_, MO_NNP )_) ;_: 1_CD or_CC 10_CD mg_NN /_NN ml_NN soybean_NN trypsin_NN
          inhibitor_NN (_( Sigma_NNP ,_, St_NNP Louis_NNP ,_, MO_NNP )_) ;_: 10_CD mg_NN /_NN ml_NN type_NN IV_NNP chick_NN
          egg_NN white_JJ purified_JJ ovoinhibitor_NN (_( Sigma_NNP ,_, St_NNP Louis_NNP ,_, MO_NNP )_) at_IN
          4_CD °_NN C_NNP overnight_JJ and_CC used_VBD the_DT next_JJ day_NN ._. Control_NN beads_NNS were_VBD
          soaked_JJ in_IN PB_NNP overnight_JJ at_IN 4_CD °_NN C_NNP and_CC used_VBD the_DT next_JJ day_NN ._.
        
        
          Free_NNP floating_VBG immunocytochemistry_NN
          
            Single_NNP label_NN
            Tissue_NNP was_VBD washed_VBN and_CC treated_VBN with_IN 0_CD ._. 5_CD %_NN hydrogen_NN
            peroxide_NN to_TO remove_VB endogenous_JJ peroxidase_NN activity_NN ._.
            Following_VBG an_DT overnight_JJ incubation_NN in_IN 0_CD ._. 1_CD %_NN Triton_NNP X-_NNP 100_CD
            (_( Tx_NNP 100_CD ,_, Sigma_NNP ,_, St_NNP Louis_NNP ,_, MO_NNP )_) containing_VBG 3_CD %_NN normal_JJ goat_NN
            serum_NN in_IN PB_NNP at_IN 4_CD °_NN C_NNP ,_, sections_NNS were_VBD incubated_JJ in_IN rabbit_NN
            polyclonal_NN anti-_NN GnRH_NNP antibody_NN (_( SW-_NNP 1_CD ,_, 1_CD :_: 5000_CD in_IN 0_CD ._. 1_CD %_NN
            Tx_NNP 100_CD in_IN PB_NNP ,_, generously_RB provided_VBN by_IN Dr_NNP ._. S_NNP ._. Wray_NNP ,_, NIH_NNP )_)
            for_IN at_IN least_JJS 4_CD days_NNS at_IN 4_CD °_NN C_NNP ._. Following_VBG three_CD PB_NNP washes_NNS ,_,
            tissue_NN was_VBD then_RB incubated_JJ in_IN biotinylated_JJ
            goat-anti-rabbit-_JJ IgG_NNP (_( 1_CD :_: 200_CD ,_, Vector_NNP Labs_NNPS ,_, Burlingame_NNP ,_,
            CA_NNP )_) in_IN 0_CD ._. 1_CD %_NN Tx_NNP 100_CD in_IN PB_NNP overnight_JJ at_IN 4_CD °_NN C_NNP ._. The_DT following_VBG
            day_NN ,_, sections_NNS were_VBD washed_VBN in_IN PB_NNP and_CC incubated_JJ in_IN
            avidin-biotin-_JJ HRP_NNP complex_JJ (_( 1_CD :_: 200_CD ,_, Vector_NNP Labs_NNPS ,_,
            Burlingane_NNP ,_, CA_NNP )_) for_IN at_IN least_JJS 3_CD hours_NNS at_IN room_NN
            temperature_NN ._. After_IN PB_NNP washes_NNS ,_, bound_VBN antibody_NN was_VBD
            detected_VBN using_VBG 3_CD ,_, 3_CD '_POS -_: diaminobenzidine_NN (_( DAB_NNP ,_, Sigma_NNP ,_, St_NNP
            Louis_NNP ,_, MO_NNP )_) as_IN the_DT chromogen_NN ._.
            Brains_NNP processed_VBD for_IN immunocytochemical_JJ localization_NN
            of_IN protease_NN ,_, PN-_NNP 1_CD or_CC axonal_NN /_NN glial_NN markers_NNS were_VBD treated_VBN
            as_IN described_VBN above_IN ,_, however_RB the_DT primary_JJ antibodies_NNS used_VBN
            were_VBD specific_JJ for_IN each_DT protein_NN (_( see_VB list_NN below_IN )_) ._.
            Sections_NNP were_VBD viewed_VBN and_CC photographed_VBN with_IN an_DT Olympus_NNP
            Vanox_NNP microscope_NN (_( New_NNP York_NNP /_NN New_NNP Jersey_NNP Scientific_NNP Inc_NNP ._. ,_,
            Middlebush_NNP ,_, NJ_NNP )_) ._.
          
          
            Double_RB label_NN
            Brains_NNP processed_VBD for_IN double_JJ label_NN immunofluorescence_NN
            were_VBD treated_VBN as_IN described_VBN above_IN ._. The_DT first_JJ antibody_NN was_VBD
            detected_VBN using_VBG the_DT appropriate_JJ biotinylated_JJ IgG_NNP
            followed_VBN by_IN avidin-fluorophore_JJ (_( either_CC Texas_NNP Red_NNP or_CC
            FITC_NNP ,_, Sigma_NNP ,_, St_NNP Louis_NNP ,_, MO_NNP )_) ,_, while_IN the_DT second_JJ antibody_NN
            was_VBD detected_VBN by_IN a_DT directly_RB conjugated_JJ IgG-fluorphore_NNP ._.
            All_DT fluorescent_NN images_NNS were_VBD acquired_VBN with_IN a_DT Zeiss_NNP
            confocal_NN microscope_NN using_VBG LSM_NNP 410_CD ._. Images_NNP were_VBD acquired_VBN
            at_IN 40_CD or_CC 100_CD X_NNP using_VBG 16_CD averaged_VBD scans_VBZ at_IN 1028_CD ×_NN 1028_CD
            pixel_NN resolution_NN and_CC printed_VBN using_VBG Adobe_NNP Photoshop_NNP
            IV_NNP ._.
          
          
            Control_NNP
            To_TO test_VB the_DT specificity_NN of_IN the_DT method_NN ,_, tissue_NN was_VBD
            processed_VBN as_IN described_VBN above_IN for_IN the_DT first_JJ antibody_NN ._. In_IN
            the_DT second_RB set_NN of_IN reactions_NNS ,_, 3_CD %_NN normal_JJ mouse_NN serum_NN
            (_( Vector_NNP Labs_NNPS ,_, Burlingane_NNP ,_, CA_NNP )_) in_IN 0_CD ._. 1_CD %_NN Tx_NNP 100_CD in_IN PB_NNP was_VBD
            substituted_VBN for_IN the_DT primary_JJ antibody_NN ._. This_DT was_VBD followed_VBN
            by_IN horse_NN anti-mouse_JJ IgG-FITC_NNP ._. Under_IN these_DT conditions_NNS ,_,
            no_DT FITC_NNP immunofluorescence_NN was_VBD detected_VBN ._. As_IN an_DT
            additional_JJ control_NN for_IN trypsin_NN immunoreactivity_NN in_IN the_DT
            CNS_NNP ,_, trypsin_NN protein_NN was_VBD incubated_JJ with_IN the_DT
            anti-trypsin_JJ antibody_NN for_IN 4_CD hours_NNS at_IN 4_CD °_NN C_NNP for_IN antibody_NN
            adsorption_NN ._. This_DT antigen_NN /_NN antibody_NN complex_NN was_VBD then_RB
            utilized_JJ to_TO immunostain_NN chick_NN tissue_NN sections_NNS ;_: no_DT
            immunoreactivity_NN was_VBD detected_VBN (_( see_VB figure_NN 3_LS )_) ._.
          
        
        
          Antibodies_NNP /_NN antisera_NN and_CC dilutions_NNS
          
            Axonal_NNP markers_NNS
            
            NCAM_NNP :_: A_DT mouse_NN monoclonal_NN antibody_NN
            raised_VBD against_IN the_DT highly_RB sialylated_JJ embryonic_JJ forms_NNS of_IN
            the_DT neural_NN cell_NN adhesion_NN molecule_NN was_VBD used_VBN (_( 1_CD :_: 1_CD ,_,
            Developmental_NNP Studies_NNPS Hybridoma_NNP Bank_NNP )_) ._.
            
            NF_NNP :_: Two_CD mouse_NN monoclonal_NN antibodies_NNS
            raised_VBD against_IN the_DT heavy_JJ (_( 200_CD kD_NN )_) and_CC light_JJ (_( 68_CD kD_NN )_)
            forms_NNS of_IN neurofilament_NN were_VBD used_VBN (_( 1_CD :_: 200_CD each_DT ,_, Sigma_NNP ,_, St_NNP
            Louis_NNP ,_, MO_NNP )_) ._. Both_DT antibodies_NNS recognize_VBP phosphorylated_JJ
            variants_NNS of_IN neurofilament_NN ._.
            
            MAP_NNP 1_CD b_SYM :_: A_DT mouse_NN monoclonal_NN antibody_NN
            to_TO the_DT microtubule_NN associated_VBN protein_NN 1_CD b_SYM was_VBD generously_RB
            provided_VBN by_IN Dr_NNP ._. Lester_NNP Binder_NNP ,_, University_NNP of_IN Alabama_NNP at_IN
            Birmingham_NNP ._. The_DT antibody_NN was_VBD used_VBN at_IN 1_CD :_: 1000_CD and_CC was_VBD
            selected_VBN because_IN MAP_NNP 1_CD b_SYM is_VBZ the_DT earliest_JJS expressed_VBN MAP_NNP
            both_DT 
            in_IN vivo_NN and_CC 
            in_IN vitro_NN [_NN 43_CD ]_NN ._.
            
            PGP_NNP 9_CD ._. 5_LS :_: A_DT rabbit_NN polyclonal_NN
            antibody_NN raised_VBD against_IN human_JJ protein_NN gene_NN product_NN 9_CD ._. 5_CD
            was_VBD used_VBN at_IN 1_CD :_: 1000_CD (_( Biogenesis_NNP ,_, Ltd_NNP ,_, ._. Poole_NNP ,_, England_NNP )_) ._.
            This_DT is_VBZ a_DT neuron-specific_JJ ubiquitin_NN carboxy_NN terminal_NN
            hydrolase_NN ._.
          
          
            Glial_NNP markers_NNS
            
            P_NN 
            0_CD :_: A_DT mouse_NN monoclonal_NN antibody_NN ,_,
            1_CD E_NNP 8_CD ,_, raised_VBD against_IN the_DT mammalian_JJ myelin_NN protein_NN ,_, P_NN 
            0_CD ,_, was_VBD used_VBN at_IN 1_CD :_: 4000_CD and_CC was_VBD
            generously_RB provided_VBN by_IN Dr_NNP ._. R_NN ._. Brackenbury_NNP (_( University_NNP
            of_IN Cincinnati_NNP ,_, Cincinnati_NNP ,_, OH_NNP )_) ._. This_DT antibody_NN
            recognizes_VBZ Schwann_NNP and_CC ensheathing_VBG cells_NNS of_IN the_DT
            olfactory_NN nerve_NN but_CC not_RB astrocytes_NNS ._.
            
            MAP_NNP 4_CD :_: A_DT mouse_NN monoclonal_NN antibody_NN
            raised_VBD against_IN microtubule_NN associated_VBN protein_NN 4_CD ,_, MAP_NNP 4_CD ,_,
            was_VBD generously_RB provided_VBN by_IN Dr_NNP ._. Chloe_NNP Bulinski_NNP (_( Columbia_NNP
            University_NNP ,_, NY_NNP ,_, NY_NNP )_) and_CC used_VBN at_IN 1_CD :_: 1000_CD ._. MAP_NNP 4_CD is_VBZ the_DT
            major_JJ MAP_NNP expressed_VBN by_IN non-neuronal_JJ tissue_NN ._.
            
            S_NNP 100_CD :_: A_DT rabbit_NN polyclonal_NN anti-_NN S_NNP 100_CD
            antibody_NN was_VBD used_VBN at_IN 1_CD :_: 1000_CD (_( Biogenesis_NNP ,_, Ltd_NNP ,_, Poole_NNP ,_,
            England_NNP )_) ._. S_NNP 100_CD is_VBZ a_DT central_JJ and_CC peripheral_JJ glial_NN cell_NN
            marker_NN ._.
          
          
            GnRHmarker_NNP
            
            GnRH_NNP :_: a_DT polyclonal_NN antibody_NN raised_VBD
            against_IN GnRH_NNP conjugated_JJ with_IN glutaraldehyde_NN to_TO
            ovalbumin_NN was_VBD generously_RB provided_VBN by_IN Dr_NNP ._. Susan_NNP Wray_NNP
            (_( NIH_NNP )_) ._. This_DT antibody_NN recognizes_VBZ amino_JJ acids_NNS :_: 3_CD ,_, 4_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_,
            and_CC 10_CD of_IN the_DT GnRH_NNP peptide_NN and_CC was_VBD used_VBN at_IN 1_CD :_: 5000_CD ._.
          
          
            Protease_NNP antibodies_NNS
            
            Trypsin_NNP :_: An_DT anti-human_JJ cationic_JJ
            trypsin_NN antibody_NN was_VBD used_VBN at_IN 1_CD :_: 1000_CD (_( Biodesign_NNP ,_,
            Kennebunk_NNP ,_, ME_NNP )_) ._.
            
            uPA_NN :_: An_DT anti-u_JJ PA_NNP antibody_NN was_VBD used_VBN
            at_IN 1_CD :_: 1000_CD (_( Accurate_NNP Chemical_NNP ,_, Westbury_NNP ,_, NY_NNP )_) ._.
          
          
            Protease_NNP inhibitor_NN antibody_NN
            
            PN-_NNP 1_CD :_: An_DT anti-rat_JJ PN-_NNP 1_CD antibody_NN was_VBD
            used_VBN at_IN 1_CD :_: 500_CD and_CC was_VBD generously_RB provided_VBN by_IN Dr_NNP ._. D_NNP ._.
            Monard_NNP (_( Friedrich_NNP Miescher_NNP Institut_NNP ,_, Basel_NNP ,_,
            Switzerland_NNP )_) ._.
          
          
            Coagulation_NNP Assay_NNP
            To_TO ensure_VB that_IN the_DT proteases_NNS and_CC inhibitors_NNS used_VBN
            were_VBD active_JJ ,_, a_DT coagulation_NN assay_NN was_VBD performed_VBN ._. Blood_NNP
            alone_RB (_( from_IN PD_NNP )_) coagulated_JJ in_IN approximately_RB 2_CD minutes_NNS ._.
            Incubation_NNP of_IN blood_NN with_IN 1_CD mg_NN /_NN ml_NN uPA_NN delayed_VBD
            coagulation_NN significantly_RB (_( by_IN several_JJ minutes_NNS )_) ._.
            Incubation_NNP with_IN combined_VBN PN-_NNP 1_CD and_CC uPA_NN resulted_VBD in_IN rapid_JJ
            coagulation_NN as_IN in_IN control_NN ._.
          
          
            Cell_NNP counts_VBZ and_CC statistical_JJ analysis_NN
            Cell_NNP counts_VBZ for_IN PN-_NNP 1_CD and_CC serine_NN proteases_NNS were_VBD
            performed_VBN by_IN PD_NNP who_WP was_VBD unaware_JJ of_IN the_DT experimental_JJ
            status_NN of_IN the_DT embryos_NNS ._. Those_DT for_IN the_DT other_JJ serine_NN
            protease_NN inhibitors_NNS were_VBD carried_VBN out_IN by_IN a_DT second_JJ
            observer_NN (_( XLZ_NNP )_) ._. Both_DT observers_NNS carried_VBD out_IN independent_JJ
            counts_NNS on_IN separately_RB prepared_VBN sets_NNS of_IN PB_NNP controls_NNS ._. An_DT
            equal_JJ number_NN of_IN immunoreactive_JJ tissue_NN sections_NNS was_VBD
            counted_VBN for_IN each_DT side_NN of_IN the_DT face_NN (_( i_NNP ._. e_SYM ._. the_DT side_NN
            containing_VBG the_DT bead_NN and_CC the_DT contralateral_NN side_NN )_) ._.
            Selected_JJ sections_NNS were_VBD recounted_VBN by_IN AJS_NNP to_TO check_VB for_IN
            accuracy_NN ._. Cell_NNP number_NN was_VBD determined_VBN via_IN a_DT modified_VBN
            optical_JJ dissector_NN method_NN [_NN 44_CD 45_CD 46_CD ]_NN ._. Examination_NNP of_IN
            tissue_NN reveals_VBZ three_CD focal_JJ planes_NNS ;_: the_DT nucleus_NN being_VBG in_IN
            crisp_JJ focus_NN in_IN only_RB one_CD of_IN these_DT planes_NNS ._. This_DT profile_NN
            allows_VBZ cells_NNS (_( nuclei_NN )_) to_TO be_VB counted_VBN in_IN each_DT of_IN the_DT
            three_CD planes_NNS ._. Double_RB counting_VBG is_VBZ avoided_VBN for_IN those_DT
            cells_NNS in_IN the_DT top_NN and_CC bottom_NN planes_NNS by_IN counting_VBG
            alternate_JJ sections_NNS ._.
            Immunoreactive_NNP GnRH_NNP neurons_NNS separated_VBN into_IN
            categories_NNS depending_VBG on_IN location_NN :_: olfactory_NN epithelium_NN
            (_( OE_NNP )_) ,_, olfactory_NN nerve_NN (_( ON_NNP )_) and_CC telencephalon_NN (_( CNS_NNP )_) ._.
            Numbers_NNPS in_IN each_DT category_NN were_VBD then_RB expressed_VBN as_IN a_DT
            percent_NN of_IN total_JJ number_NN of_IN GnRH_NNP neurons_NNS on_IN that_DT side_NN of_IN
            the_DT face_NN ._. The_DT contralateral_NN side_NN served_VBD as_IN a_DT within_IN
            animal_NN control_NN ._. To_TO analyze_VB for_IN significant_JJ differences_NNS
            in_IN percentage_NN of_IN GnRH_NNP neurons_NNS in_IN each_DT category_NN ,_, an_DT
            unpaired_JJ students_NNS t-test_JJ (_( p_NN <_NN 0_CD ._. 05_CD )_) was_VBD
            performed_VBN ._.
          
        
      
    
  
